This suggests that E2F1 rs3213180, located in 3’UTR, plays a pivotal role in lymph node metastasis, resulting in a more aggressive LSCC phenotype predisposing patients to a higher clinical stage (ST). The gene discussed is E2F1; the disease is metastatic malignant neoplasm in the lymph nodes.